Dr Lalchandani Labs Ltd — Important, 31-01-2026: Company Update

The company's board has approved the financial results for the quarter and half-year ended September 30, 2023. Further, the board gave a green light to raise funds up to ₹100 Cr through methods like private placement or QIP. A significant Rights Issue of up to ₹1,000 Cr was also approved, targeting existing shareholders. These funds are intended to support capital expenditure, working capital needs, and other general corporate initiatives, aiming to strengthen the company’s financial health and future growth.